FDA calendar
Upcoming FDA decision dates, advisory committee meetings and EU opinions, alongside recent FDA decisions and announcements. Updated automatically every day from the FDA newsroom, openFDA, the Federal Register and company announcements.
Coming up
November 2026
- 22SunPDUFA dateCapricor Therapeutics · DeramiocelDuchenne muscular dystrophy · Cell therapy BLA; date extended after major amendmentCapricor (SEC filing) ↗
- 27FriPDUFA dateBridgeBio Pharma · BBP-418Limb-girdle muscular dystrophy type 2I/R9 · Priority reviewPR Newswire ↗
- 30Mon
- 30MonPDUFA dateVertex Pharmaceuticals · PovetaciceptIgA nephropathy · Accelerated approval, priority reviewPR Newswire ↗
December 2026
- 3Thu
- 12Sat
- 27SunPDUFA datePraxis Precision Medicines · RelutrigineSCN2A and SCN8A developmental and epileptic encephalopathiesPraxis ↗
- 27SunPDUFA dateViatris · MR-107A-02 (fast-acting meloxicam)Moderate-to-severe acute pain · Non-opioidPR Newswire ↗
- 30Wed
January 2027
- 21ThuPDUFA dateDyne Therapeutics · Zeleciment rostudirsen (DYNE-251)Duchenne muscular dystrophy, exon 51 · Accelerated approval, priority reviewNeurologyLive ↗
- 29Fri
- 30SatPDUFA datePharming · Joenja (leniolisib)APDS in younger children · Paediatric label expansion, priority reviewRallies ↗
June 2027
- 29Tue
Recent FDA decisions and announcements
Nothing in the last four months.
